Clinically Relevant Response to Treatment with Olaparib in a Patient with Refractory Multidrug-Resistant Ovarian Cancer and Central Nervous System Involvement: A Case Report

Flavia Morales Vázquez; Horacio Noé López Basave; María del Carmen Méndez Herrera; Ricardo Raziel Peña González

doi:10.12659/AJCR.925990

23 November 2020 : Case report Mexico

Clinically Relevant Response to Treatment with Olaparib in a Patient with Refractory Multidrug-Resistant Ovarian Cancer and Central Nervous System Involvement: A Case Report

Unusual or unexpected effect of treatment

Flavia Morales Vázquez^1ABCDEFG*, Horacio Noé López Basave^2BDEF, María del Carmen Méndez Herrera^3BCDE, Ricardo Raziel Peña González^4BCF

DOI: 10.12659/AJCR.925990

Am J Case Rep 2020; 21:e925990

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 3. Magnetic resonance imaging of the head 23 months after the first visit (A: Midline plane; B: Coronal plane). The arrows point to metastatic lesions.

Back to the Article

Clinically Relevant Response to Treatment with Olaparib in a Patient with Refractory Multidrug-Resistant Ovarian Cancer and Central Nervous System Involvement: A Case Report

Your Privacy